The DOI matches its Crossref record; 39 of the 44 references it cites were found in a registry or an index.
The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF
Open accessAbstract
Interleukin 17 (IL-17)-producing helper T cells (T(H)17 cells) require exposure to IL-23 to become encephalitogenic, but the mechanism by which IL-23 promotes their pathogenicity is not known. Here we found that IL-23 induced production of the cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) in T(H)17 cells and that GM-CSF had an essential role in their encephalitogenicity. Our findings identify a chief mechanism that underlies the important role of IL-23 in autoimmune diseases. IL-23 induced a positive feedback loop whereby GM-CSF secreted by T(H)17 cells stimulated the production of IL-23 by antigen-presenting cells. Such cross-regulation of IL-23 and GM-CSF explains the similar pattern of resistance to autoimmunity when either of the two cytokines is absent and identifies T(H)17 cells as a crucial source of GM-CSF in autoimmune inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“and to promote the production of effector molecules (El-Behi et al., 2011).”
From Distinct characteristics of hippocampal pathogenic th17 cells in a mouse model of depression (2018) · cites this paper as El-Behi et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., Cherwinski, H. M., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,553
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 1×
“The initial development of T H 17 cells from naive CD4 + T cells is directed by transforming growth factor-β (TGF-β) in combination with IL-6, IL-21 or IL-9 (refs”
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jäger, A., Strom, T. B., Oukka, M., & Kuchroo, V. K. (2007) · Nature · doi:10.1038/nature05970 · Cited by 1,896
McGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T., & Cua, D. J. (2007) · Nature Immunology · doi:10.1038/ni1539 · Cited by 1,520
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Ghoreschi, K., Laurence, A., Yang, X.-P., Tato, C. M., McGeachy, M. J., Konkel, J. E., Ramos, H. L., Wei, L., Davidson, T. S., Bouladoux, N., et al. (2010) · Nature · doi:10.1038/nature09447 · Cited by 1,388
Reboldi, A., Coisne, C., Baumjohann, D., Benvenuto, F., Bottinelli, D., Lira, S., Uccelli, A., Lanzavecchia, A., Engelhardt, B., & Sallusto, F. (2009) · Nature Immunology · doi:10.1038/ni.1716 · Cited by 1,206 · cited 1×
“The CCR6-CCL20 axis is essential for the entry of T H 17 cells into the CNS in the early phase of EA”
Research works printed but not linked: 6
- McGeachy, M.J. et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat. Immunol. 10, 314–324 (2009). · DOI · Paper page
- Park, L.S., Friend, D., Gillis, S. & Urdal, D.L. Characterization of the cell surface receptor for granulocyte-macrophage colony-stimulating factor. J. Biol. Chem. 261, 4177–4183 (1986). · DOI
- Fleetwood, A.J., Lawrence, T., Hamilton, J.A. & Cook, A.D. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 178, 5245–5252 (2007). · DOI · Paper page
- Hirota, K. et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12, 255–263 (2011). · DOI · Paper page
- Yang, X.O. et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors RORα and RORγ. Immunity 28, 29–39 (2008). · DOI · Paper page
- Yamazaki, T. et al. CCR6 regulates the migration of inflammatory and regulatory T cells. J. Immunol. 181, 8391–8401 (2008). · DOI
Cited by
Sorted by citations
Items 701–800 of 955
Li, D., Li, J.-Y., Liu, H., Zhai, L.-N., Hu, W.-L., Xia, N., Tang, T., Jiao, J., Lv, B.-J., Nie, S., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101576r · Cited by 13
Vallejo, A. N., Mroczkowski, H. J., Michel, J. J., Woolford, M., Blair, H. C., Griffin, P. C., McCracken, E., Mihalik, S. J., Reyes‐Múgica, M., & Vockley, J. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1304 · Cited by 12
“In addition, we detected IL-6, IL-8 and GM-CSF, which are known to cross-regulate TNFa, with GMCSF also cross-regulating IL-17.(49,50) Such crosstalk between cytokines explains the preponderance of T cells, B cells and monocytes with high intracellular stores of IL-6, MIP-1b (CCL4), IFNc and TNFa.”
BackgroundDrohomyrecky, P. C., Doroshenko, E. R., Akkermann, R., Moshkova, M., Yi, T. J., Zhao, F. L., Ahn, J. J., McGaha, T. L., Pahan, K., & Dunn, S. E. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801200 · Cited by 18
“8B), and IL-12p70 and IL-1b were not detectable above background levels (data not shown).”
BackgroundInfluentialDimitrijević, M., Arsenović-Ranin, N., Bufan, B., Nacka-Aleksić, M., Macanović, M., Milovanović, P., Durić, M., Sopta, J., & Leposavić, G. (2018) · Experimental and molecular pathology (Print) · doi:10.1016/j.yexmp.2018.05.007 · Cited by 13
Stojić-Vukanić, Z., Kotur‐Stevuljević, J., Nacka-Aleksić, M., Kosec, D. J., Vujnović, I., Pilipović, I., Dimitrijević, M., & Leposavić, G. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0595-2 · Cited by 13
“Additionally, IFN-γ- and GM-CSF-producing (IFN-γ+GM-CSF+) IL-17+ T cells are found to be highly pathogenic in mouse EAE models [44, 45] and positively correlated with severity of neurological deficit in DA rat EAE model [22].”
BackgroundStojić-Vukanić, Z., Nacka-Aleksić, M., Pilipović, I., Vujnović, I., Blagojević, V., Kosec, D. J., Dimitrijević, M., & Leposavić, G. (2015) · Immunity & Ageing · doi:10.1186/s12979-015-0044-x · Cited by 15
“The expression of the cytokines (IL-1β and IL-23/p19) driving GM-CSF + IL-17 + IFN-γ + cell differentiation in mice was also augmented in aged rat spinal cord mononuclear cells.”
BackgroundInfluentialAstrocyte-derived lactosylceramide implicated in multiple sclerosis
Rostami, A., & Ciric, B. (2014) · Nature Medicine · doi:10.1038/nm.3719 · Cited by 13
Self-citationDuarte, J., Carrié, N., Oliveira, V. G., Almeida, C., Agua-Doce, A., Rodrigues, L., Simas, J. P., Mars, L. T., & Graca, L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201269 · Cited by 13
GM-CSF distinctly impacts human monocytes and macrophages via ERK1/2-dependent pathways
Farzam‐kia, N., Moratalla, A. C., Lemaître, F., Levert, A., Cal, S. D., Margarido, C., Solorio, Y. C., & Arbour, N. (2023) · Immunology Letters · doi:10.1016/j.imlet.2023.07.009 · Cited by 14
Recent Progress in Multiple Sclerosis Treatment Using Immune Cells as Targets
Ma, X., Ma, R., Zhang, M., Qian, B., Wang, B. B., & Yang, W. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030728 · Cited by 17
Adrenoceptors as Potential Target for Add-On Immunomodulatory Therapy in Multiple Sclerosis
Pilipović, I., Stojić-Vukanić, Z., & Leposavić, G. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108358 · Cited by 11
Transcription Factor RUNX3 Mediates Plasticity of ThGM Cells Toward Th1 Phenotype
Rasouli, J., Casella, G., Zhang, W., Xiao, D., Kumar, G., Fortina, P. M., Zhang, G., Ćirić, B., & Rostami, A. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.912583 · Cited by 12
“IL-23 is another cytokine that has been shown to induce Th1-like phenotype in Th17 cells (1).”
BackgroundSelf-citationLong Intergenic Noncoding RNA MIAT as a Regulator of Human Th17 Cell Differentiation
Khan, M. M., Khan, M. H., Ullah, U., Khan, S., Junttila, S., Paulin, N., Kong, L., Rasool, O., Elo, L. L., & Lahesmaa, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.856762 · Cited by 12
“Interestingly, CXCL13 and CSF2 have been associated with autoimmune diseases (33, 44).”
BackgroundFlorou, D., Mavropoulos, Α., Dardiotis, E., Tsimourtou, V., Siokas, V., Aloizou, A., Liaskos, C., Tsigalou, C., Katsiari, C. G., Sakkas, L. I., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.739186 · Cited by 16
Chen, H., Wang, C., Li, J., Huandike, M., Liu, J., Huang, Q., Li, X., Zhang, H., Zhou, J., & Chai, L. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/1706837 · Cited by 11
Hu, Y., Xu, F., Zhang, R., Legarda, D., Dai, J., Wang, D., Li, H., Zhang, Y., Xue, Q., Dong, G., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.04.010 · Cited by 13
Zhang, T., Ma, J., Durbin, K. R., Montavon, T. J., Lacy, S. E., Jenkins, G. J., Doktor, S. Z., & Kalvass, J. C. (2019) · The AAPS Journal · doi:10.1208/s12248-019-0352-8 · Cited by 12
Dendritic Cells in Multiple Sclerosis
Melnikov, M., Пащенков, М. В., & Бойко, А. Н. (2018) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-018-0615-3 · Cited by 2
Hernández-Mir, G., & McGeachy, M. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173655 · Cited by 16
Commanding CNS invasion: GM-CSF
Zhao, J.-J., Sun, L. D., & Li, X.-X. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.003 · Cited by 12
“The GM-CSF-expanded inflammatory MdCs are capable of producing IL-1b and ROS, which breach the blood-brain barrier and activate the microglia.”
BackgroundInfluentialPulmonary resident neutrophils regulate the production of GM ‐ CSF and alveolar macrophages
Tian, F., Han, Y. C., Song, J., Lei, J., Yan, X., Xie, N., Song, J., Zhao, J., Liang, X., Zhong, D., et al. (2016) · FEBS Journal · doi:10.1111/febs.13684 · Cited by 14
Inflammation‐associated genes: risks and benefits to Foxp3+ regulatory T‐cell function
O’Connor, R. A., & Anderton, S. M. (2015) · Immunology · doi:10.1111/imm.12507 · Cited by 15
“79 Inducible Treg cells can also produce granulocyte-macrophage colony-stimulating factor (GM-CSF) upon secondary stimulation, 82 which is of relevance given the central role of this cytokine in EAE. 83, 84 However, production of GM-CSF by iTreg cells is susceptible to inhibition by IL-6, IL-27, IL-2 and TGF-b.”
BackgroundImmune Responses to Non-Tumor Antigens in the Central Nervous System
Huber, A. K., Duncker, P. C., & Irani, D. N. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00328 · Cited by 11
“GM-CSF can also increase HLA class II expression and proinflammatory cytokine production by microglia, macrophages, and DC in vitro (209, 210).”
BackgroundXie, L., Chen, J., McMickle, A., Awar, N., Nady, S., Sredni, B., Drew, P., & Yu, S.-G. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.05.015 · Cited by 12
Metabolic Control of Th17 Cell Generation and CNS Inflammation
Chi, H. (2013) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.s12-004 · Cited by 11
“IL-23 induces the expression of GM-CSF by Th17 cells, which in turn enhances the production of IL-23 by dendritic cells (DCs) [8,9].”
Suppressive Oligodeoxynucleotides Promote the Development of Th17 Cells
Bode, C., Yang, X., Kiu, H., & Klinman, D. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067991 · Cited by 10
“A milieu rich in TGFb and depleted of IL-23 favors the generation of non-pathogenic IL-10-producing Th17 cells while an environment with high levels of IL-23 support the expansion of autoreactive Th17 cells [11–14].”
BackgroundModeling a complex disease: Multiple sclerosis—Update 2020
Regen, T., & Waisman, A. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.03.002 · Cited by 16
Kurschus, F. C., Wörtge, S., & Waisman, A. (2011) · Advances in immunology · doi:10.1016/b978-0-12-387663-8.00001-6 · Cited by 10
Alomar, H. A., Nadeem, A., Ansari, M. A., Attia, S. M., Bakheet, S. A., Al‐Mazroua, H. A., Alhazzani, K., Assiri, M. A., Alqinyah, M., Almudimeegh, S., et al. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.01.003 · Cited by 13
“Several inflammatory mediators released by different immune cells are known to infiltrate the CNS of mouse models of experimental autoimmune encephalomyelitis (EAE) (Peron et al., 2010).”
BackgroundInfluentialScavenger Receptor BI Attenuates IL-17A-dependent Neutrophilic Inflammation in Asthma.
Reece, S., Varikuti, S., Kilburg‐Basnyat, B., Dunigan-Russell, K., Hodge, M., Luo, B., Madenspacher, J., Thomas, S. Y., Tokarz, D., Tighe, R., et al. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0007oc · Cited by 11
Letscher, H., Agbogan, V. A., Korniotis, S., Gastineau, P., Tejerina, E., Gras, C., Mégret, J., Moe, A., Drobyski, W., & Zavala, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-84023-0 · Cited by 11
Safavi, F., Thomé, R., Li, Z.-C., Zhang, G.-X., & Rostami, A. (2020) · Neurology: Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000729 · Cited by 11
Self-citationQin, S., Vodovotz, L., Zamora, R., Fitzpatrick, M., Kessinger, C., Kingsley, L., McMahon, D., DeSensi, R., Leader, J., Crothers, K., et al. (2020) · Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002234 · Cited by 11
Moorman, C. D., Curtis, A. D., Bastian, A. G., Elliott, S. E., & Mannie, M. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03119 · Cited by 11
Uyttenhove, C., Gaignage, M., Donckers, D., Nasr, Z., Cheou, P., Snick, J. V., D'Auria, L., & van Pesch, V. (2018) · European Journal of Immunology · doi:10.1002/eji.201847580 · Cited by 11
Macrophages - silent enemies in juvenile idiopathic arthritis.
Świdrowska-Jaros, J., Orczyk, K., & Smolewska, E. (2016) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.1208887 · Cited by 11
IL-12Rβ2 has a protective role in relapsing–remitting experimental autoimmune encephalomyelitis
Xie, C., Ćirić, B., Yu, S., Zhang, G., & Rostami, A. M. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.12.009 · Cited by 12
“Th17 cells play a critical role in EAE and it is believed that they are more pathogenic than Th1 cells (El-Behi et al., 2011; Langrish et al., 2005); enhanced Th17 response may therefore be one of the reasons for more severe EAE in IL-12Rβ2−/−mice.”
InfluentialSelf-citationMechanisms of Cholera Toxin in the Modulation of TH17 Responses
Tsai, H., & Wu, R. (2015) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2015012295 · Cited by 10
T cell-macrophage crosstalk in GVHD and cancer immunotherapy
Song, Q., Chaudagar, K. K., Zhang, X., & Waller, E. K. (2025) · Cell investigation. · doi:10.1016/j.clnves.2025.100035 · Cited by 9
Parween, F., Singh, S. P., Kathuria, N., Zhang, H. H., Ashida, S., Otaizo-Carrasquero, F. A., Shamsaddini, A., Gardina, P. J., Ganesan, S., Kabát, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57002-6 · Cited by 13
“The critical effector cytokines that have been shown to mediate these cells ’ pathogenic activity have included GM-CSF 31,46,49 – 53 , IFN-γ 31,44 , and IL-17 52 .”
Zhong, X., Wu, H., Zhang, W., Shi, Y., Gwack, Y., Xue, H., & Sun, Z. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114951 · Cited by 11
SENP2 restrains the generation of pathogenic Th17 cells in mouse models of colitis
Yang, T.-T., Chiang, M.-F., Chang, C.-C., Yang, S.-Y., Huang, S.-W., Liao, N., Shih, H.-M., Hsu, W., & Lin, K.-I. (2023) · Communications Biology · doi:10.1038/s42003-023-05009-4 · Cited by 10
“Pathogenic Th17 cells also produce granulocyte macrophage-colony stimulating factor (GM-CSF), which is critical for the pathogenicity of Th17 cells in in fl ammation 13,14 .”
Immunological Aspects of Von Hippel-Lindau Disease: A Focus on Neuro-Oncology and Myasthenia Gravis
Norata, D., Peri, M., Giammalva, G. R., Lupica, A., Paolini, F., Incorvaia, L., Badalamenti, G., Gristina, V., Galvano, A., Russo, A. D., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13010144 · Cited by 10
Lu, Y., Xu, M., Dorrier, C., Zhang, R., Mayer, C. T., Wagner, D. H., McGavern, D. B., & Hodes, R. J. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200439 · Cited by 10
Mosure, S., Wilson, A. N., & Solt, L. A. (2022) · Immunometabolism · doi:10.20900/immunometab20220006 · Cited by 10
Nguyen, N. Z. N., Tran, V. G., Lee, S., Kim, M., Kang, S. W., Kim, J., Kim, H. J., Lee, J. S., Cho, H. R., & Kwon, B. (2020) · Immune Network · doi:10.4110/in.2020.20.e49 · Cited by 14
“GM-CSF is a pleiotropic cytokine produced by a variety of cell types, including lymphoid cells such as NK cells, Th17 cells, invariant NKT cells, type 2 innate lymphoid cells (ILC2s), and ILC3s (12-14,29-33).”
BackgroundSkogman, B. H., Lager, M., Brudin, L. H., Jenmalm, M. C., Tjernberg, I., & Henningsson, A. J. (2020) · Ticks and Tick-borne Diseases · doi:10.1016/j.ttbdis.2020.101390 · Cited by 12
Seledtsov, V., Malashchenko, V., Gazatova, N. D., Meniailo, M. E., Morozova, E., & Seledtsova, G. V. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1614396 · Cited by 10
“(DCs), which not only initiate antigen-dependent proliferation and differentiation of T cells,(1,2) but also support many mechanisms underlying adaptive immune reactivity.(3,4) Importantly, GMCSF is produced both in central hematopoietic organs and in the periphery, and its production is dramatically increased in tiss…”
BackgroundYou, Z., Timilshina, M., Jeong, B.-S., & Chang, J.-H. (2017) · European Journal of Immunology · doi:10.1002/eji.201646860 · Cited by 10
Däbritz, J., Weinhage, T., Varga, G., Wirth, T., Ehrchen, J., Barczyk-Kahlert, K., Roth, J., Schwarz, T., & Foell, D. (2016) · European Journal of Immunology · doi:10.1002/eji.201545802 · Cited by 10
Perspectives on cytokine-directed therapies in multiple sclerosis
Schreiner, B., & Becher, B. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14199 · Cited by 10
Zhan, J.-Y., Luo, R., Li, C., Zhong, L., Wu, Q., Wang, R., Chen, D.-P., Chen, X., Ren, K.-Y., Chen, Z., et al. (2025) · Journal of Infection · doi:10.1016/j.jinf.2025.106642 · Cited by 10
Interplay between fungal infections and autoimmunity: mechanisms and therapeutic perspectives
DiPalma, D. T., Lumbreras, M., & Shinohara, M. L. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00262-y · Cited by 10
“…such as G-CSF, M-CSF, and GM-CSF, enhance myelopoiesis and fungal clearance (Bandera et al, 2008; Du et al, 2020; Nemunaitis et al, 1993), but GM-CSF is particularly linked to autoimmune diseases as a detrimental factor in MS (Codarri et al, 2011; El-Behi et al, 2011; McQualter et al, 2001).”
Siffrin, V. (2025) · Glia · doi:10.1002/glia.70044 · Cited by 10
“Key factors include the master transcription factor RORγt which drives Th17 cell differentiation (Ivanov et al. 2006), IL-23, which stabilizes Th17 cells, and GMCSF, which mediates the manifestation of clinical signs of EAE (McGeachy et al. 2009; Codarri et al. 2011; El-Behi et al. 2011).”
Audia, S., Brescia, C., Dattilo, V., Torchia, N., Trapasso, F., & Amato, R. (2024) · Cancers · doi:10.3390/cancers17010055 · Cited by 11
Stober, C. B., Ellis, L., GOODALL, J. C., Veldhoen, M., & Gaston, H. (2024) · Arthritis & Rheumatology · doi:10.1002/art.43095 · Cited by 11
“35,36 In contrast to murine studies in which IL-23 augments GM-CSF, 11,12 we show that GM-CSF is negatively regulated by IL-23 in human Th 17 and Th 1 cells.”
Milne, S. M., Lahiri, A., Sanchez, C. L., Marshall, M. J., Jahan, I., & Meares, G. P. (2024) · Scientific Reports · doi:10.1038/s41598-024-63877-0 · Cited by 10
A T H 17-intrinsic IL-1β–STAT5 axis drives steroid resistance in autoimmune neuroinflammation
Miller-Little, W. A., Chen, X., Salazar, V., Liu, C., Bulek, K., Zhou, J. Y., Xiao, L., Stüve, O., Stappenbeck, T. S., Dubyak, G., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.abq1558 · Cited by 10
Mudalagiriyappa, S., Sharma, J., Vieson, M. D., & Nanjappa, S. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111543 · Cited by 9
“Consistent with this idea, studies have identified a non-redundant role for GM-CSF in cooperating with Th17 cells during autoimmune neuroinflammation (Codarri et al., 2011; El-Behi et al., 2011; Lee et al., 2012).”
BackgroundResultPathological Role of Pin1 in the Development of DSS-Induced Colitis
Matsunaga, Y., Hasei, S., Yamamotoya, T., Honda, H., Kushiyama, A., Sakoda, H., Fujishiro, M., Ono, H., Ito, H., Okabe, T., et al. (2021) · Cells · doi:10.3390/cells10051230 · Cited by 11
“DC cells and macrophages produce cytokines IL-6, IL-23 and IL-1β and then drive Th17 cells to produce IL-17 [17].”
BackgroundInfluentialAram, J., Frakich, N., Morandi, E., Alrouji, M., Samaraweera, A. P. R., Onion, D., Spendlove, I., Colombo, S., Tanasescu, R., Gran, B., et al. (2020) · Biomedicines · doi:10.3390/biomedicines8070226 · Cited by 9
Cytokines as Mediators of Neuroinflammation in Experimental Autoimmune Encephalomyelitis
Gogoleva, V. S., Атретханы, К.-С. Н., Drutskaya, M. S., Mufazalov, I. A., Kruglov, A., & Nedospasov, S. A. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918090110 · Cited by 13
IL-3 Is a Marker of Encephalitogenic T Cells, but Not Essential for CNS Autoimmunity
Lee, P. W., Xin, M., Pei, W., Yang, Y.-H., & Lovett-Racke, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01255 · Cited by 9
“Since the Il3 allele is located in the same gene cluster with Csf2 (encodes GMCSF) on chromosome 11 in mouse and chromosome 5 in human (Figure 1G) and GMCSF was found to be critical for encephalitogenic T cells (17, 21, 23, 24), we analyzed GMCSF+activated CD4 T cells via flow cytometry.”
BackgroundTranslational utility of experimental autoimmune encephalomyelitis: recent developments
Jagodic, M., Guerreiro‐Cacais, A. O., Lindahl, H., Flytzani, S., N’diaye, M., & Olsson, T. P. (2015) · Journal of Inflammation Research · doi:10.2147/jir.s76707 · Cited by 6
“68 Since GM-CSF is the only T-cell effector cytokine shown to date to be absolutely essential for EAE induction, 69,70 the results of this study come to resolve the conundrum.”
BackgroundT Cell-Derived GM-CSF, Regulation of Expression and Function
Sheng, W. (2015) · Immunome Research · doi:10.4172/1745-7580.1000098 · Cited by 8
“demonstrated that both antigen-specific TH1 and TH17 are encephalitogenic and that GM-CSF expression by either TH1 or TH17 cells was required for their encephalitogenicity in mice [15].”
BackgroundResultInfluentialMechanisms of immunological tolerance in central nervous system inflammatory demyelination
Mari, E. R., Moore, J. N., Zhang, G., & Rostami, A. M. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12196 · Cited by 8
Self-citationReichwald, K., Jørgensen, T. Z., & Skov, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105627 · Cited by 9
“GM-CSF is up-regulated in several autoimmune diseases, and is directly responsible for the encephalitogenicity of the Th17 cells mediating disease in an EAE mouse model [24,25].”
Cellular aspects of immunity involved in the development of atherosclerosis
Khalaf, K., Chamieh, M., Welc, N. A., Singh, C., Kaouk, J. L., Kaouk, A., Mackiewicz, A. A., Kaczmarek, M., & Perek, B. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1461535 · Cited by 10
Gonçalves, L. T. C., Neves, G. S. T., da Silva, A. M. P., Telles, D. D. M., Figueredo, C. M., Lourenço, E. J. V., & Teixeira, M. K. S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020340 · Cited by 10
Yazdani, R., Naziri, H., Azizi, G., Ciric, B., Askari, M., Ahmadi, A. M., Aseervatham, J., Zhang, G.-X., & Rostami, A. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03295-1 · Cited by 8
Self-citationThe immunologic role of IL-23 in psoriatic arthritis: a potential therapeutic target
Su, Q. Y., Gao, H.-Y., Duan, Y.-R., Luo, J., Wang, W.-Z., Qiao, X.-C., & Zhang, S. (2024) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2024.2401148 · Cited by 9
Su, J., Hu, W., Ding, Y., Zhang, P., Li, T.-F., Liu, S., & Xing, L. (2024) · Arthritis Research & Therapy · doi:10.1186/s13075-024-03373-y · Cited by 8
“Proinflammatory cytokines (IL-6, IL-1 and IL-23) are well characterized as an enhancer and stabilizer of effector Th17 cells [30, 31].”
BackgroundSur, M., Rasquinha, M. T., Mone, K., Massilamany, C., Lasrado, N., Gurumurthy, C. B., Sobel, R. A., & Reddy, J. (2024) · Cells · doi:10.3390/cells13030234 · Cited by 10
GM-CSF Protects Macrophages from DNA Damage by Inducing Differentiation
Vico, T., Youssif, C., Zare, F., Comalada, M., Sebastián, C., Lloberas, J., & Celada, A. (2022) · Cells · doi:10.3390/cells11060935 · Cited by 12
“Ly6Chigh monocytes in an inflammatory locus differentiate into macrophages with a proinflammatory profile, releasing a number of molecules (IL-1α, IL-1β, TNF-α and IL-12) that activate helper T cells and induce the production of GM-CSF [66,67].”
BackgroundMurray, M. P., Crosby, C., Marcovecchio, P. M., Hartmann, N., Chandra, S., Zhao, M., Khurana, A., Zahner, S., Clausen, B., Coleman, F., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110209 · Cited by 8
“Further, IL-23 has been shown to stimulate GM-CSF production by CD4+ Th17 cells, although it is not known if this is true for iNKT cells (Codarri et al., 2011; El-Behi et al., 2011; Rothchild et al., 2014).”
BackgroundMyocarditis and carotidynia caused by Granulocyte-Colony stimulating factor administration
de la Fuente, E. C., Barquín, A., Saavedra, C., Domingo, J. J. S., Huertas, R. M., Fernández-Abad, M., & Martínez-Jáñez, N. (2020) · Modern Rheumatology Case Reports · doi:10.1080/24725625.2020.1754552 · Cited by 9
The Effects of Anti-IL-23p19 Therapy on Atherosclerosis Development in ApoE −/− Mice
Wang, J., Zhao, P., Gao, Y., Zhang, F., Yuan, X., Jiao, Y., & Gong, K. (2019) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2019.0050 · Cited by 11
Effect of 50-Hz Magnetic Fields on Serum IL-1β and IL-23 and Expression of BLIMP-1, XBP-1, and IRF-4
Molaei, S., Behzad, M., Gholamian-Hamadan, M., Zaerieghane, Z., & Zamani, A. (2019) · Inflammation · doi:10.1007/s10753-019-01042-w · Cited by 8
Novel Therapeutic Targets in Axial Spondyloarthritis
Worth, C., Bowness, P., & Al-Mossawi, M. (2018) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-018-0095-1 · Cited by 8
Interleukin 23 in IBD Pathogenesis
Eken, A., & Oukka, M. (2016) · InTech eBooks · doi:10.5772/64882 · Cited by 7
“More importantly, independent studies revealed that GMCSF is required for classical EAE development in mice, especially by activating microglia or mobilizing inflammatory myeloid lineages to the inflammation site [109, 110].”
BackgroundReynolds, B. C., Turner, D. G., McPherson, R. C., Prendergast, C. T., Phelps, R. G., Turner, N. A., O’Connor, R. A., & Anderton, S. M. (2014) · European Journal of Immunology · doi:10.1002/eji.201444687 · Cited by 9
Eislmayr, K., Langner, C. A., Liu, F. L., Yuvaraj, S., Babirye, J. P., Roncaioli, J. L., Vickery, J., Barton, G. M., Lesser, C. F., & Vance, R. E. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.08.001 · Cited by 10
SiglecF Expressing Neutrophils Exacerbate Th17-Mediated Autoimmune Neuroinflammation
Hu, W., Kwon, L., Jeong, Y. S., Bae, G. H., Kim, Y. S., Zabel, B. A., & Bae, Y. (2025) · Immune Network · doi:10.4110/in.2025.25.e19 · Cited by 8
“We examined IL-6, known to collaborate with TGF-β in promoting Th17 differentiation, along with IL-23 and IL-1 β , which have been implicated in inducing pathogenic GM-CSF-producing Th17 subsets (29).”
Early involvement of peripherally derived monocytes in inflammation in an NMO-like mouse model
Kim, M., Kim, W., Cha, H., Kim, B., Kwon, Y. N., & Kim, S. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-51759-4 · Cited by 10
“IL-1β plays a role in the expansion of GM-CSF-producing Th17 cells 29 , breakdown of the blood–brain barrier (BBB) 30 , activation of microglia 31 , and promotion of IL-1β production/secretion to amplify inflammation.”
The roles of lncRNAs in Th17-associated diseases, with special focus on JAK/STAT signaling pathway
Wang, H., Yu, L., Cheng, L., & Guo, Z. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01181-3 · Cited by 6
“Given that GM-CSF plays a vital function in Th17 cells for encephalitogenicity in mice [19, 21], the observation that active MS patients with relapsing–remitting type had increased levels of GM-CSF in their cerebrospinal fluid and serum as well as enhanced GM-CSF production of T cells from their…”
BackgroundAlsaad, A. M. S., Ansari, M. A., Nadeem, A., Attia, S. M., Bakheet, S. A., Alomar, H. A., & Ahmad, S. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612991 · Cited by 5
“Recent data have also shown that GM-CSF is activated in the disease progression and pathogenicity of EAE [19].”
BackgroundGATA3 induces the pathogenicity of Th17 cells via regulating GM-CSF expression
Butcher, M. J., Gurram, R. K., Zhu, X., Chen, X., Hu, G., Lazarevic, V., Zhao, K., & Zhu, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1186580 · Cited by 7
“As prior work has demonstrated that GM-CSF is an effector cytokine critically required for the recruitment and activation of CNS mononuclear cells and for EAE induction (22, 23, 48), the inability of late tamoxifen-treated Cre-ERT2-Gata3 CD4 effector cells to produce GM-CSF likely explains why these transferred CD4”
ResultAriki, S., Ozaka, S., Sachi, N., Chalalai, T., Soga, Y., Fukuda, C., Kagoshima, Y., Ekronarongchai, S., Mizukami, K., Kamiyama, N., et al. (2023) · Genes to Cells · doi:10.1111/gtc.13008 · Cited by 9
New insights into the immunologic role of oligodendrocyte lineage cells in demyelination diseases
Li, H., Chen, Y., Niu, J., & Yi, C. (2022) · Journal of Biomedical Research · doi:10.7555/jbr.36.20220016 · Cited by 10
Agasing, A. M., Quinn, J. L., Kumar, G., & Axtell, R. (2021) · Cells · doi:10.3390/cells10082139 · Cited by 7
“Rec ntly, it has been reported that GM-CSF is a key cytokine produc by TH cells which pro otes neuroinflammation [17].”
BackgroundMaria, Z., Turner, E., Agasing, A. M., Kumar, G., & Axtell, R. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062924 · Cited by 9
“Since GM-CSF-producing Th17 cells have been reported to be crucial for the induction of EAE [31,32], we speculated that the delayed disease onset and severity could be attributed to the restricted entry of this encephalitogenic T cell subset into the CNS.”
BackgroundThe Effect of Cannabis on the Clinical and Cytokine Profiles in Patients with Multiple Sclerosis
Mustafa, W., Elgendy, N., Salama, S., Jawad, M., & Eltoukhy, K. (2021) · Multiple Sclerosis International · doi:10.1155/2021/6611897 · Cited by 7
“It induces polarization of T cells toward Th17 cells, which are the key cells in MS [64].”
BackgroundZhang, Y., Wei, Z., Dong, H. F., Zhou, J., Yuan, J., Ni, B., Wu, Y., Han, C., & Tian, Y. (2020) · RNA Biology · doi:10.1080/15476286.2020.1862567 · Cited by 17
“induce autoimmune neuroinflammation [67,68].”
Cytokines and Transgenic Matrix in Autoimmune Diseases: Similarities and Differences
Szewczak, L., & Donskow-Łysoniewska, K. (2020) · Biomedicines · doi:10.3390/biomedicines8120559 · Cited by 7
“GM-CSF production by Th17 cells is stimulated by IL-23 and further GM-CSF production gives a positive feedback loop for APC (antigen presenting cells) to produce IL-23 [30].”
BackgroundInfluentialMoon, J., Lee, S. H., Lee, S.-Y., Ryu, J., Jhun, J., Choi, J., Kim, G. N., Roh, S., Park, S., & Cho, M. (2020) · Immune Network · doi:10.4110/in.2020.20.e40 · Cited by 7
“Myelin-reactive T cells that produce IFNγ, IL-17, and GM-CSF are associated with the disabilities of EAE (32-37).”
BackgroundZhao, W., Xiang, Y.-G., Zhang, Z., Liu, X., Jiang, M.-L., Jiang, B., Song, Y., & Hu, J.-Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106447 · Cited by 7
Usefulness of animal models of aspergillosis in studying immunity against Aspergillus infections
Mirkov, I. I., Aleksandrov, A. P., Lazovic, B., Glamočlija, J., & Kataranovski, M. V. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.01.006 · Cited by 10
Cummings, M., Arumanayagam, A., Zhao, P., Kannanganat, S., Stüve, O., Karandikar, N., & Eagar, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200752 · Cited by 7
“GSI treatment did not impact the frequency of T cells expressing GM-CSF suggesting a mechanism to explain the lack of clinical efficacy of GSI treatment [7, 13, 14, 76, 77].”
Nacka-Aleksić, M., Stojić-Vukanić, Z., Pilipović, I., Vujnović, I., Bufan, B., Dimitrijević, M., & Leposavić, G. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.03.001 · Cited by 8
Éliás, S., Schmidt, A., Kannan, V., Andersson, J., & Tegner, J. N. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00603 · Cited by 6
“level In previous studies, a fraction of GM-CSF+ cells has been found to co-express some other cytokines, but this has not been tested on single-cell level in all studies (5, 11, 13, 14, 18, 35).”
BackgroundInfluential
Metadata
- Authors
- El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G.-X., Dittel, B. N., & Rostami, A.
- Affiliations
- Thomas Jefferson University (US)
- Versiti Blood Center of Wisconsin (US)
- Corresponding author
- Rostami, Abdolmohamad
- ORCID
- Venue
- Nature Immunology
- Published
- 2011-04-24
- Volume
- 12
- Issue
- 6
- Pages
- 568-575
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC3116521
- OpenAlex
- W2084388036
- Cited by
- 1,071
- References
- 44
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 38 · 2023: 58 · 2022: 62 · 2021: 72 · 2020: 82 · 2019: 71 · 2018: 74 · 2017: 96 · 2016: 82 · 2015: 108 · 2014: 91 · 2013: 80 · 2012: 73
- FWCI
- 37.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Multiple Sclerosis Society
- Mary E. Groff Surgical and Medical Research and Education Charitable Trust
- National Institute of Neurological Disorders and Stroke (R01NS046782)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- Th17 cells, experimental autoimmune encephalomyelitis, IL-23, GM-CSF, interleukin-1, encephalitogenicity, autoimmune disease, antigen-presenting cells, positive feedback loop, T helper cells
- MeSH terms
- Animals, Antibodies, Cells, Cultured, Encephalomyelitis, Autoimmune, Experimental, Female, Flow Cytometry, Glycoproteins, Interleukin-1, Mice, Inbred C57BL, Mice, Transgenic, Peptide Fragments, CD4-Positive T-Lymphocytes, Granulocyte-Macrophage Colony-Stimulating Factor, Transforming Growth Factor beta, Mice, Knockout, Th1 Cells, Coculture Techniques, CD11c Antigen, Mice, Interleukin-1beta, Interleukin-23, Nuclear Receptor Subfamily 1, Group F, Member 3, Th17 Cells, Myelin-Oligodendrocyte Glycoprotein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review